PS
BNTX icon

Principal Securities’s BioNTech BNTX Stock Holding History

Principal Securities’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-97
Closed -$9.57K – 1607
2025
Q3 		$9.57K Buy
97
+34
+54% +$3.63K ﹤0.01% 2739
2025
Q2 		$6.71K Sell
63
-34
-35% -$3.43K ﹤0.01% 2780
2025
Q1 		$11.1K Hold
97
– – ﹤0.01% 2479
2024
Q4 		$11.1K Sell
97
-5
-5% -$571 ﹤0.01% 2475
2024
Q3 		$12.1K Sell
102
-48
-32% -$4.41K ﹤0.01% 2349
2024
Q2 		$12.1K Sell
150
-4
-3% -$366 ﹤0.01% 2312
2024
Q1 		$14.2K Buy
154
+29
+23% +$2.78K ﹤0.01% 2177
2023
Q4 		$13.2K Buy
+125
New +$12.6K ﹤0.01% 2123

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Securities's BNTX Position: Q4 2025 in Review

Principal Securities sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 97 shares — an estimated $9.57K sold.

Principal Securities first reported a position in BNTX in Q4 2023 and held it in 8 quarters. The position peaked at $14.2K in Q1 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Principal Securities reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 97 BioNTech shares in Q4 2025, an estimated $9.57K.
  • Principal Securities first reported a position in BioNTech in Q4 2023 and held it in 8 quarters.
  • Principal Securities's BioNTech position peaked at $14.2K in Q1 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.